Lactoferrin

Generic Name: Lactoferrin

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 151186-19-5

Unique Ingredient Identifier: -

Background: Lactoferrin is under investigation in clinical trial NCT03748043 (The Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Lactoferrin for Treatment of Iron Deficiency Anemia.

Phase 4

Completed

Conditions: Anemia, Iron Deficiency

Interventions: Drug: Ferrous Sulfate
Drug: Lactoferrin

First Posted Date: 2020-06-17

Last Posted Date: 2020-06-17

Lead Sponsor: Cairo University

Target Recruit Count: 90

Registration Number: NCT04435574

Locations: 🇪🇬
Primary care center, Giza, Egypt

Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19

Phase 2

Conditions: COVID-19

Interventions: Drug: Lactoferrin

First Posted Date: 2020-06-09

Last Posted Date: 2020-06-09

Lead Sponsor: Cairo University

Target Recruit Count: 150

Registration Number: NCT04421534

Safety and Efficacy of Oral Bovine Lactoferrin

Early Phase 1

Completed

Conditions: Neonatal SEPSIS

Interventions: Drug: Placebos
Drug: Lactoferrin

First Posted Date: 2019-09-19

Last Posted Date: 2019-09-19

Lead Sponsor: Cairo University

Target Recruit Count: 200

Registration Number: NCT04094597

Locations: 🇪🇬
Ayman, Assiut, Assuit, Egypt

Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students

Phase 2

Completed

Conditions: Iron Deficiency Anemia

Interventions: Drug: Ferrous sulfate
Drug: Lactoferrin

First Posted Date: 2019-05-07

Last Posted Date: 2020-05-28

Lead Sponsor: yasmin gamal el gendy

Target Recruit Count: 90

Registration Number: NCT03940430

Locations: 🇪🇬
Ain Shams University, Cairo, Egypt

Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy

Phase 2

Completed

Conditions: Iron Deficiency Anemia

Interventions: Diagnostic Test: Baseline ferritin level
Drug: Ferrous Sulfate
Drug: Lactoferrin
Diagnostic Test: Follow up ferritin level

First Posted Date: 2018-11-30

Last Posted Date: 2018-11-30

Lead Sponsor: Ain Shams University

Target Recruit Count: 98

Registration Number: NCT03759353

Locations: 🇪🇬
Ain SHams Maternity Hospital, Cairo, Abbaseya, Egypt

the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis

Phase 4

Conditions: Iron-deficiency

Interventions: Drug: Lactoferrin
Drug: Ferric Hydroxide Polymaltose

First Posted Date: 2018-11-20

Last Posted Date: 2019-03-19

Lead Sponsor: South Valley University

Target Recruit Count: 100

Registration Number: NCT03748043

Locations: 🇪🇬
South Valley University, Qinā, Egypt

Oral Lactoferrin Versus Iron Supplementation During Pregnancy

Phase 4

Completed

Conditions: Iron-deficiency

Interventions: Drug: Chelates, Iron
Drug: Iron Supplement
Drug: Lactoferrin

First Posted Date: 2018-05-31

Last Posted Date: 2018-12-28

Lead Sponsor: South Valley University

Target Recruit Count: 300

Registration Number: NCT03542825

Locations: 🇪🇬
South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department, Qinā, Qena, Egypt

Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy

Phase 2

Completed

Conditions: Iron Deficiency Anemia of Pregnancy

Interventions: Drug: Lactoferrin
Drug: ferrous sulphate + folic acid (vitamin B9)

First Posted Date: 2018-03-29

Last Posted Date: 2018-03-29

Lead Sponsor: Ain Shams Maternity Hospital

Target Recruit Count: 200

Registration Number: NCT03481790

Locations: 🇪🇬
Ain Shams Maternity Hospital, Cairo, Egypt

Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis

Phase 4

Completed

Conditions: Neonatal Sepsis

Interventions: Drug: Placebo (for Lactoferrin)
Drug: Lactoferrin

First Posted Date: 2016-11-09

Last Posted Date: 2016-11-09

Lead Sponsor: Ain Shams University

Target Recruit Count: 180

Registration Number: NCT02959229

Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: Lactoferrin

First Posted Date: 2016-07-26

Last Posted Date: 2016-07-26

Lead Sponsor: Università degli Studi di Ferrara

Target Recruit Count: 60

Registration Number: NCT02843984

Locations: 🇮🇹
Obstetric Unit, University of Ferrara, Cona, Ferrara, Italy

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy